Methacryloxyethyl-trimethylammonium bromide | 68912-04-9

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: Methacryloxyethyl-trimethylammonium bromide
• 英文别名: trimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium;bromide
• CAS: 68912-04-9
• 化学式: C9H18BrNO2
• 分子量: 252.15
• InChiKey: FGKCGMMQJOWMFW-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  -2.18
• 重原子数：
  13
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• [EN] MACROMOLECULAR PRODRUGS FOR HARD TISSUE AND METHODS OF USE THEREOF<br/>[FR] PROMÉDICAMENTS MACROMOLÉCULAIRES POUR TISSU DUR ET LEURS PROCÉDÉS D'UTILISATION
  申请人：NEW YORK SOC RUPTURED & CRIPPLED MAINTAINING HOSPITAL FOR SPECIAL SURGERY

  公开号：WO2014036548A1

  公开（公告）日：2014-03-06

  Compositions for intravenous administration and methods for treating bone diseases, disorders, and fractures comprising macromolecular prodrugs of hydrophobic bone anabolic agents are provided. Specifically, novel macromolecular amphiphilic prodrugs wherein at least three molecules of simvastatin are conjugated to polyethylene glycol, which spontaneously form micelles in aqueous solutions are provided.

  提供用于静脉给药的组成物以及包括疏水性骨骼合成剂的巨分子前药治疗骨骼疾病、紊乱和骨折的方法。具体而言，提供新颖的巨分子两亲性前药，其中至少三分子辛伐他汀与聚乙二醇共轭，它们在水溶液中自发形成胶束。
• RADIATION ENHANCED MACROMOLECULAR DELIVERY OF THERAPEUTIC AGENTS FOR CHEMOTHERAPY
  申请人：UNIVERSITY OF UTAH RESEARCH FOUNDATION

  公开号：US20160166693A1

  公开（公告）日：2016-06-16

  Described herein are anti-cancer compounds composed of a macromolecule comprising (1) at least one anti-cancer agent directly or indirectly bonded to the macromolecule and (2) at least one high Z element directly or indirectly bonded to the macromolecule that is capable of producing Auger electrons upon exposure to X-ray energy. When the compounds are exposed to low energy X-ray (e.g., kilo electron volts KeV) Auger electrons are produced by the high Z elements present in the compound. Because lower energy is required when compared to typical radiotherapy, which uses therapeutic X-ray energy in the million electron volt range (MeV), the subject experiences lower collateral damage when compared to radiation therapy. Additionally, the presence of the anti-cancer agent provides a second mechanism for killing cancer cells. Methods for making and using the anti-cancer compounds are also described herein.

  本文描述了一种抗癌化合物，由包括（1）至少一种直接或间接与大分子结合的抗癌药物和（2）至少一种直接或间接与大分子结合的高Z元素组成，该高Z元素在暴露于X射线能量时能够产生奥古尔电子。当这些化合物暴露于低能量X射线（例如，千电子伏特KeV）时，化合物中存在的高Z元素会产生奥古尔电子。与使用百万电子伏特范围内的治疗性X射线能量（MeV）的典型放射疗法相比，所需的能量更低，因此受试者在与放射疗法相比时经历较低的附带损伤。此外，抗癌药物的存在提供了杀死癌细胞的第二机制。本文还描述了制备和使用抗癌化合物的方法。
• Methods of manufacturing deodorants, and deodorants resulting thereof
  申请人：Hu Jinlian

  公开号：US20050232880A1

  公开（公告）日：2005-10-20

  This invention provides a deodorant capable of releasing deodorant agents at certain temperatures and having improved adherence to textiles. The deodorant of this invention includes polymer particles formed by reacting a main monomer of (N-substituted alkyl)acrylamide, a functional monomer for bonding the polymer particles to a fibrous substrate, and a cross-linking agent. A deodorant agent is loaded to the polymer particles.

  这项发明提供了一种能够在特定温度释放除臭剂并具有改善对纺织品附着性的除臭剂。该发明的除臭剂包括由反应主单体（N-取代烷基）丙烯酰胺、用于将聚合物颗粒与纤维基质结合的功能单体以及交联剂形成的聚合物颗粒。除臭剂被加载到聚合物颗粒中。
• [EN] MACROMOLECULAR DELIVERY SYSTEMS FOR NON-INVASIVE IMAGING, EVALUATION AND TREATMENT OF ARTHRITIS AND OTHER INFLAMMATORY DISEASES<br/>[FR] SYSTEMES D'ADMINISTRATION MACROMOLECULAIRES DESTINES A L'IMAGERIE, A L'EVALUATION ET AU TRAITEMENT NON INVASIFS DE L'ARTHRITE ET D'AUTRES MALADIES INFLAMMATOIRES
  申请人：UNIV UTAH RES FOUND

  公开号：WO2005097073A1

  公开（公告）日：2005-10-20

  This invention relates to biotechnology, more particularly, to water-soluble polymeric delivery systems for the imaging, evaluation and/or treatment of rheumatoid arthritis and other inflammatory diseases. Using modern MR imaging techniques, the specific accumulation of macromolecules in arthritic joints in adjuvant-induced arthritis in rats is demonstrated. The strong correlation between the uptake and retention of the MR contrast agent labeled polymer with histopathological features of inflammation and local tissue damage demonstrates the practical applications of the macromolecular delivery system of the invention.

  本发明涉及生物技术，更具体地说，涉及用于成像、评估和/或治疗类风湿性关节炎和其他炎症性疾病的水溶性高分子递送系统。利用现代磁共振成像技术，证明了大分子在大鼠佐剂诱导性关节炎中的关节特异性积累。MR对比剂标记的聚合物的摄取和保留与炎症和局部组织损伤的组织病理学特征之间的强相关性证明了本发明的高分子递送系统的实际应用。
• METHOD FOR PRODUCING ORGANIC TELLURIUM COMPOUND AND METHOD FOR PRODUCING VINYL POLYMER
  申请人：OTSUKA CHEMICAL CO., LTD

  公开号：US20220009885A1

  公开（公告）日：2022-01-13

  Provided is a method for producing an organic tellurium compound that enables the production of an organic tellurium compound in high yield using metallic tellurium as a source material and produces less amount of side products. A method for producing an organic tellurium compound includes the steps of: (A) reacting metallic tellurium with a compound represented by a general formula (1) below; and (B) reacting a compound obtained by the step (A) with an organic halogen compound, the metallic tellurium having a copper content of less than 100 ppm, M(R 1 )m   Formula (1) where R 1 represents an alkyl group having 1 to 8 carbon atoms, an aryl group or an aromatic heterocyclic group, M represents an alkali metal or an alkaline earth metal, m represents 1 when M is an alkali metal, and m represents 2 when M is an alkaline earth metal.

  提供了一种制备有机碲化合物的方法，该方法使用金属碲作为原材料，使得有机碲化合物的产率高且产生的副产物较少。制备有机碲化合物的方法包括以下步骤：(A)将金属碲与下面通式(1)所代表的化合物反应；(B)将由步骤(A)得到的化合物与有机卤化合物反应，其中金属碲中铜的含量小于100 ppm，M(R1)m  式(1)，其中R1代表1至8个碳原子的烷基、芳基或芳香族杂环基，M代表碱金属或碱土金属，当M为碱金属时，m为1，当M为碱土金属时，m为2。